http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5409456-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8f7f2b4e5865e08c4b8590d51cd56145
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S128-13
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H20-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M5-172
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M5-172
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16H20-17
filingDate 1992-09-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1995-04-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d9c0860e8f4f61122e661fbf11301837
publicationDate 1995-04-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-5409456-A
titleOfInvention Method for intravenous drug infusion
abstract A method and system for the infusion of a drug into a patient involving: (i) calculating a multiplicity of infusion rate profiles for a selected drug by monitoring drug efflux from the body of a group of patients for a corresponding multiplicity of target concentrations of the selected drug; (ii) determining the body size of the patient, such as their Lean Body Mass; (iii) selecting a target concentration of the drug to, in turn, cause selection from the multiplicity of infusion rate profiles of an infusion rate profile substantially corresponding to the infusion rate profile for the selected target concentration; (iv) scaling the selected infusion rate profile by the determined body size or Lean Body Mass of the patient; and (v) administering the drug to the patient in accordance with the scaled profile by means of an infusion device which is controlled to deliver said drug at said scaled infusion rate profile. By using the aforesaid method and system, drugs which are non-linear in their effect on a patient are able to be delivered to the patient in a much more accurate manner thereby avoiding overdosing or underdosing of the drug and the undesirable consequences thereof.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014121255-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5807316-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-10342162-A1
priorityDate 1991-09-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-8400894-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4880014-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4502488-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5254087-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4741732-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-3809871-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226422309
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4943
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128824437

Total number of triples: 28.